Neumora Therapeutics NMRA
NASDAQ NMRA
$0.50 -0.05 (-9.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Return on Invested Capital [ROIC] (2025 - 2026)

Updated

Neumora Therapeutics' Return on Invested Capital [ROIC] came in at -191.10% for Q2 2026, down 32.91 percentage points from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Return on Invested Capital [ROIC] (2025 - 2026) Analysis & Trends

For FY2025, Neumora Therapeutics' Return on Invested Capital [ROIC] was -108.27%.

  • Business Quant data shows NMRA's Return on Invested Capital [ROIC] at -158.19% (Q1 2026), -155.52% (Q4 2025) and -138.73% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Neumora Therapeutics 93.95 Mn 93.95 Mn - -191.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -191.10%
Mar 31, 2026 -158.19%
Dec 31, 2025 -155.52%
Sep 30, 2025 -138.73%
API Access

Neumora Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEY